Literature DB >> 9469334

Life after breast cancer: understanding women's health-related quality of life and sexual functioning.

P A Ganz1, J H Rowland, K Desmond, B E Meyerowitz, G E Wyatt.   

Abstract

PURPOSE: To describe the health-related quality of life (HRQL), partner relationships, sexual functioning, and body image concerns of breast cancer survivors (BCS) in relation to age, menopausal status, and type of cancer treatment. PATIENTS AND METHODS: A cross-sectional sample of BCS in two large metropolitan areas was invited to participate in a survey study that included the following standardized measures: the RAND 36-Item Health Survey; the Centers for Epidemiologic Studies-Depression Scale (CES-D); the Dyadic Adjustment Scale (DAS); the Breast Cancer Prevention Trial (BCPT) Symptom Checklist; the Watts Sexual Functioning Questionnaire (WSFQ); and subscales from the Cancer Rehabilitation Evaluation System (CARES).
RESULTS: Eight hundred sixty-four BCS completed the survey. RAND Health Survey scores were as good or better than those of healthy, age-matched women, and the frequency of depression was similar to general population samples. Marital/partner adjustment was similar to normal healthy samples, and sexual functioning mirrored that of healthy, age-matched postmenopausal women. However, these BCS reported higher rates of physical symptoms (eg, joint pains, headaches, and hot flashes) than healthy women. Sexual dysfunction occurred more frequently in women who had received chemotherapy (all ages), and in younger women who were no longer menstruating. In women > or = 50 years, tamoxifen therapy was unrelated to sexual functioning.
CONCLUSION: BCS report more frequent physical and menopausal symptoms than healthy women, yet report HRQL and sexual functioning comparable to that of healthy, age-matched women. Nevertheless, some survivors still experience poorer functioning, and clinicians should inquire about common symptoms to provide symptomatic management or counseling for these women.

Entities:  

Mesh:

Year:  1998        PMID: 9469334     DOI: 10.1200/JCO.1998.16.2.501

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  212 in total

1.  Responsiveness of the EuroQol in breast cancer patients undergoing high dose chemotherapy.

Authors:  B Conner-Spady; C Cumming; J M Nabholtz; P Jacobs; D Stewart
Journal:  Qual Life Res       Date:  2001       Impact factor: 4.147

2.  Quality of life and coping of women treated for breast cancer and their caregiver. What are the interactions?

Authors:  Angélique Bonnaud-Antignac; Jean-Benoit Hardouin; Julie Leger; François Dravet; Véronique Sebille
Journal:  J Clin Psychol Med Settings       Date:  2012-09

3.  Measuring musculoskeletal symptoms in cancer survivors who receive hematopoietic cell transplantation.

Authors:  Karen L Syrjala; Jean C Yi; Samantha B Artherholt; Allison C Stover; Janet R Abrams
Journal:  J Cancer Surviv       Date:  2010-05-08       Impact factor: 4.442

4.  Cancer survivors' responses to daily stressors: implications for quality of life.

Authors:  Erin S Costanzo; Robert S Stawski; Carol D Ryff; Christopher L Coe; David M Almeida
Journal:  Health Psychol       Date:  2012-01-23       Impact factor: 4.267

5.  Quality of life, fatigue and depression in Italian long-term breast cancer survivors.

Authors:  Francesca Romito; Claudia Cormio; Francesco Giotta; Giuseppe Colucci; Vittorio Mattioli
Journal:  Support Care Cancer       Date:  2012-03-08       Impact factor: 3.603

6.  Health-related quality of life in long-term breast cancer survivors: differences by adjuvant chemotherapy dose in Cancer and Leukemia Group B study 8541.

Authors:  Electra Paskett; James Herndon; Kathleen Donohue; Michelle Naughton; Stephen Grubbs; Michael Pavy; Martee Hensley; Nancy Stark; Alice Kornblith; Marisa Bittoni
Journal:  Cancer       Date:  2009-03-01       Impact factor: 6.860

7.  Physical Activity and Lymphedema (the PAL trial): assessing the safety of progressive strength training in breast cancer survivors.

Authors:  Kathryn H Schmitz; Andrea B Troxel; Andrea Cheville; Lorita L Grant; Cathy J Bryan; Cynthia R Gross; Leslie A Lytle; Rehana L Ahmed
Journal:  Contemp Clin Trials       Date:  2009-01-08       Impact factor: 2.226

8.  Survivorship: sexual dysfunction (female), version 1.2013.

Authors:  Crystal S Denlinger; Robert W Carlson; Madhuri Are; K Scott Baker; Elizabeth Davis; Stephen B Edge; Debra L Friedman; Mindy Goldman; Lee Jones; Allison King; Elizabeth Kvale; Terry S Langbaum; Jennifer A Ligibel; Mary S McCabe; Kevin T McVary; Michelle Melisko; Jose G Montoya; Kathi Mooney; Mary Ann Morgan; Tracey O'Connor; Electra D Paskett; Muhammad Raza; Karen L Syrjala; Susan G Urba; Mark T Wakabayashi; Phyllis Zee; Nicole McMillian; Deborah Freedman-Cass
Journal:  J Natl Compr Canc Netw       Date:  2014-02       Impact factor: 11.908

9.  Validating the content of a brief informational intervention to empower patients and spouses facing breast cancer: perspectives of both couple members.

Authors:  Marie-Claude Blais; Elizabeth Maunsell; Sophie Grenier; Sophie Lauzier; Michel Dorval; Sylvie Pelletier; Stéphane Guay; André Robidoux; Louise Provencher
Journal:  J Cancer Surviv       Date:  2014-04-27       Impact factor: 4.442

10.  Vaginal Estrogen Therapy for Patients with Breast Cancer.

Authors:  M Moegele; S Buchholz; S Seitz; C Lattrich; O Ortmann
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-10       Impact factor: 2.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.